Hospital stocks face pressure amid Supreme Court drug pricing concerns

Stocks of Indian hospital companies have declined following the Supreme Court's inquiry into high mark-ups on cancer medicines. The court questioned the government on the applicability of the 16% trade margin for such drugs.